Literature DB >> 21937914

Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves.

Chiara De Nuccio1, Antonietta Bernardo, Roberta De Simone, Enrico Mancuso, Valerio Magnaghi, Sergio Visentin, Luisa Minghetti.   

Abstract

We have previously shown that natural (15-deoxy-Δ-prostaglandin J2) and synthetic (pioglitazone) agonists of peroxisome proliferator-activated receptor γ (PPAR-γ) strengthen the intrinsic cellular mechanisms protecting oligodendrocyte (OL) progenitors (OPs) from oxidative insults and promote their differentiation. Here, we demonstrate that repeated administrations of PPAR-γ agonists to OP cultures accelerate their differentiation to OLs, as indicated by increased numbers of O4- and O1-positive cells that show increased myelin basic protein expression, elaborated cholesterol-enrichedmembranes and have increased peroxisomes. Moreover, PPAR-γ agonist-treated OLs show increased activity of the mitochondrial respiratory chain Complex IV and an increased ability to respond to environmental signals, such as adenosine diphosphate (ADP), with oscillatory Ca waves; the latter closely correlated with the presence of mitochondria and were inhibited by the mitochondrial respiratory chain Complex I inhibitor rotenone. Because Ca oscillations and mitochondrial respiratory chain activity play crucial roles in OL differentiation, these findings suggest that PPAR-γ agonists could protect OLs and promote myelination through several mechanisms, including those involving mitochondrial functions. Our studies support the therapeutic potential of PPAR-γ agonists in brain diseases in which mitochondrial alteration, oxidative stress, and demyelination occur and point to the need for a better understanding of the role of PPAR-γ and its agonists in OL biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937914     DOI: 10.1097/NEN.0b013e3182309ab1

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

1.  CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells.

Authors:  Govindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Sudhanshu P Raikwar; Ramasamy Thangavel; Duraisamy Kempuraj; Iuliia Dubova; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-27       Impact factor: 4.147

Review 2.  Interplay between transcriptional control and chromatin regulation in the oligodendrocyte lineage.

Authors:  Marylens Hernandez; Patrizia Casaccia
Journal:  Glia       Date:  2015-05-12       Impact factor: 7.452

Review 3.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

4.  Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.

Authors:  Qinyong Ye; Wanling Huang; Dongzhu Li; Erwang Si; Juhua Wang; Yingqing Wang; Chun Chen; Xiaochun Chen
Journal:  Mol Neurobiol       Date:  2015-07-04       Impact factor: 5.590

Review 5.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

6.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

7.  Cyclophilin D-dependent oligodendrocyte mitochondrial ion leak contributes to neonatal white matter injury.

Authors:  Zoya Niatsetskaya; Sergey Sosunov; Anna Stepanova; James Goldman; Alexander Galkin; Maria Neginskaya; Evgeny Pavlov; Vadim Ten
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 8.  Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders.

Authors:  Jan Spaas; Lieve van Veggel; Melissa Schepers; Assia Tiane; Jack van Horssen; David M Wilson; Pablo R Moya; Elisabeth Piccart; Niels Hellings; Bert O Eijnde; Wim Derave; Rudy Schreiber; Tim Vanmierlo
Journal:  Cell Mol Life Sci       Date:  2021-03-10       Impact factor: 9.261

Review 9.  PPAR agonists as therapeutics for CNS trauma and neurological diseases.

Authors:  Shweta Mandrekar-Colucci; Andrew Sauerbeck; Phillip G Popovich; Dana M McTigue
Journal:  ASN Neuro       Date:  2013-12-18       Impact factor: 4.146

10.  Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats.

Authors:  Jiann-Horng Yeh; Kuo-Ching Wang; Asuka Kaizaki; Jonathan W Lee; Han-Chi Wei; Michelle A Tucci; Norma B Ojeda; Lir-Wan Fan; Lu-Tai Tien
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.